TWI602912B - Contact lenses care solution - Google Patents
Contact lenses care solution Download PDFInfo
- Publication number
- TWI602912B TWI602912B TW105128206A TW105128206A TWI602912B TW I602912 B TWI602912 B TW I602912B TW 105128206 A TW105128206 A TW 105128206A TW 105128206 A TW105128206 A TW 105128206A TW I602912 B TWI602912 B TW I602912B
- Authority
- TW
- Taiwan
- Prior art keywords
- weight
- parts
- maintenance
- contact lenses
- contact lens
- Prior art date
Links
Landscapes
- Eyeglasses (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
Description
本發明係有關於一種隱形眼鏡保養液,且特別是關於一種可提高隱形眼鏡保濕性之具清潔功能的保養液。 The present invention relates to a contact lens maintenance solution, and more particularly to a maintenance liquid having a cleaning function which can improve the moisturization of a contact lens.
配戴隱形眼鏡的過程中,當配戴者的眼球表面接觸隱形眼鏡時,即會開始產生蛋白質或/與脂質的沉澱,在長時間配戴隱形眼鏡的情況下,配戴者的眼睛易感到乾澀,因而降低配戴舒適性。當蛋白質逐漸堆積後,會導致配戴者的產生視力不清、角膜充血、結膜炎、角膜新生血管、角膜潰瘍等問題,更嚴重則會使細菌孳生,使得配戴者的眼球易受到感染。因此,每日進行隱形眼鏡的清潔是相當重要的。 In the process of wearing contact lenses, when the wearer's eye surface is in contact with the contact lens, protein or/and lipid precipitation will begin to occur. In the case of wearing contact lenses for a long time, the wearer's eyes are easy to feel. Drying, thus reducing wearing comfort. When the protein gradually accumulates, it will cause the wearer to have unclear vision, corneal congestion, conjunctivitis, corneal neovascularization, corneal ulcer and other problems. More serious, the bacteria will be born, making the wearer's eyeball susceptible to infection. Therefore, daily cleaning of contact lenses is quite important.
為了有效清潔隱形眼鏡,需將隱形眼鏡鏡片浸泡於保養液一段時間,使鏡片上的蛋白質或/與脂質被分解,以達到清潔的功效。然而當隱形眼鏡經長時間浸泡清潔液後,鏡片表面會吸附清潔液中成分而對眼睛造成刺激,配戴舒適性會不如以往。故已有隱形眼鏡保養液利用添加舒緩劑、保濕劑或等張劑等添加劑以減緩配戴時所產生的不適感,於前述添加劑中,已知可於保養液中添加0.2至1.5重量百分比的甘油作為保濕劑。 In order to effectively clean the contact lens, the contact lens should be immersed in the maintenance liquid for a period of time, so that the protein or/and the lipid on the lens are decomposed to achieve the cleaning effect. However, when the contact lens is immersed in the cleaning solution for a long time, the surface of the lens absorbs the components in the cleaning liquid and causes irritation to the eyes, and the wearing comfort is not as good as before. Therefore, the contact lens maintenance solution has been added with additives such as a soothing agent, a moisturizer or an isotonic agent to alleviate the discomfort generated during wearing. Among the aforementioned additives, it is known to add 0.2 to 1.5% by weight to the maintenance liquid. Glycerin acts as a humectant.
本發明係提供一種可提高隱形眼鏡保濕性之具清潔功能的保養液以解決上述問題,即於保養液中添加了一種新穎的保濕劑, 其包含具乙烯乙醯胺之聚合物、海藻酸以及甘油,此保濕劑可提供生物相容性及低細胞毒性,降低眼睛過敏或紅腫現象,並於隱形眼鏡清潔後具良好潤濕性,以改善長期配戴所造成眼睛乾澀及痠脹。 The invention provides a cleaning liquid with a cleaning function capable of improving the moisturizing property of a contact lens to solve the above problem, that is, a novel moisturizing agent is added to the maintenance liquid. It contains a polymer with ethylene acetamide, alginic acid and glycerin. This humectant provides biocompatibility and low cytotoxicity, reduces eye irritation or redness, and has good wettability after contact lens cleaning. Improve dry eyes and soreness caused by long-term wear.
本發明所提供之用於隱形眼鏡的保養液,其包括一緩衝液、一螯合劑、一界面活性劑以及一保濕劑,該保濕劑包含100重量份甘油、0.5至40重量份的含乙烯乙醯胺之聚合物及5至40重量份之海藻酸。 The maintenance liquid for contact lenses provided by the invention comprises a buffer, a chelating agent, a surfactant and a humectant, the humectant comprising 100 parts by weight of glycerin and 0.5 to 40 parts by weight of ethylene-containing B A polymer of guanamine and 5 to 40 parts by weight of alginic acid.
本發明之用於隱形眼鏡保養液的保濕劑中需包含特定比例的具乙烯乙醯胺之合物、海藻酸及甘油,一方面為具良好生物相容性及低細胞毒性及促使保濕劑易吸附於隱形眼鏡上,另一方面因甘油使用量低,故可避免保濕劑於眼球及鏡片中所形成的保濕層過度吸附眼球表面的水分子,而影響淚腺分泌。 The humectant for the contact lens maintenance solution of the present invention needs to contain a specific ratio of ethylene acetamide, alginic acid and glycerin, on the one hand, having good biocompatibility and low cytotoxicity and promoting humectant Adsorption on contact lenses, on the other hand, due to the low use of glycerin, it can prevent the moisturizing layer formed by the moisturizer in the eyeball and lens from excessively adsorbing water molecules on the surface of the eyeball, thereby affecting the secretion of lacrimal gland.
本發明之用於隱形眼鏡保養液的保濕劑較佳在100重量份甘油含有1至35重量份的含乙烯乙醯胺之聚合物及10至35重量份之海藻酸。 The humectant for contact lens maintenance liquid of the present invention preferably contains 1 to 35 parts by weight of a polymer containing ethylene acetamide and 10 to 35 parts by weight of alginic acid in 100 parts by weight of glycerin.
本發明之用於隱形眼鏡保養液的保濕劑中所使用的具乙烯乙醯胺之聚合物係可為乙烯乙醯胺均聚物或乙烯乙醯胺共聚物,乙烯乙醯胺均聚物係由乙烯乙醯胺單體聚合而成。乙烯乙醯胺共聚物係由乙烯乙醯胺單體及其他具可交聯官能基之單體聚合而成,前述其他具可交聯官能基之單體例如可為丙烯酸鈉。 The ethylene acetamide polymer used in the humectant for contact lens maintenance liquid of the present invention may be ethylene acetamide homopolymer or ethylene acetamide copolymer, ethylene acetamide homopolymer system. It is formed by polymerization of ethylene acetylamine monomer. The ethylene acetamide copolymer is obtained by polymerizing a vinyl acetamide monomer and other monomers having a crosslinkable functional group, and the other monomer having a crosslinkable functional group may be, for example, sodium acrylate.
於本發明之一實施例,本發明之隱形眼鏡保養液中的保濕劑添加量為100重量份的緩衝液加入約為0.01重量份至0.20重量份,較佳為0.04重量份至0.14重量份。 In one embodiment of the present invention, the amount of the humectant added to the contact lens maintenance solution of the present invention is from about 0.01 part by weight to 0.20 part by weight, preferably from 0.04 part by weight to 0.14 part by weight, based on 100 parts by weight of the buffer.
於本發明之一實施例,本發明之隱形眼鏡保養液中的保濕劑可進一步包含玻尿酸。 In an embodiment of the present invention, the humectant in the contact lens maintenance solution of the present invention may further comprise hyaluronic acid.
於本發明之一實施例,本發明之隱形眼鏡保養液的保濕 劑中可進一步加入20至70重量份之玻尿酸。 In one embodiment of the present invention, the contact lens maintenance solution of the present invention is moisturized Further, 20 to 70 parts by weight of hyaluronic acid may be added to the agent.
於本發明之一實施例,本發明之隱形眼鏡保養液中,保濕劑之各組分可經混合後添加於緩衝液或可個別添加至緩衝液。 In an embodiment of the present invention, in the contact lens maintenance solution of the present invention, the components of the humectant may be added to the buffer after mixing or may be separately added to the buffer.
於本發明之一實施例,本發明之隱形眼鏡保養液中的緩衝液係由去離子水與選自由氯化鈉、硼酸及其鹽、磷酸及其鹽、硝酸及其鹽、酒石酸及其鹽、碳酸及其鹽、碳酸氫鹽、乳酸及其鹽、檸檬酸及其鹽、醋酸及其鹽、多元醇及其衍生物及磺酸及其衍生物所組成之群組所組成。前述鹽類例如可為鹼金屬鹽,如鈉鹽或鉀鹽,但不限於此。 In one embodiment of the present invention, the buffer solution in the contact lens maintenance solution of the present invention is selected from the group consisting of deionized water and selected from the group consisting of sodium chloride, boric acid and salts thereof, phosphoric acid and salts thereof, nitric acid and salts thereof, tartaric acid and salts thereof. And consisting of carbonic acid and its salts, hydrogencarbonate, lactic acid and its salts, citric acid and its salts, acetic acid and its salts, polyols and their derivatives, and sulfonic acids and their derivatives. The aforementioned salts may be, for example, an alkali metal salt such as a sodium salt or a potassium salt, but are not limited thereto.
於本發明之一實施例,本發明之隱形眼鏡保養液中的螯合劑係選自由乙二胺四乙酸(EDTA)及其鹽、聚磷酸鹽(polyphosphates)及其鹽、琥珀酸(succinic acid)及其鹽、酒石酸(tartaric acid)及其鹽、四醋酸(tetraacetic acid)及其鹽所組成之群組。前述鹽類例如可為鹼金屬鹽,如鈉鹽或鉀鹽,但不限於此。 In one embodiment of the present invention, the chelating agent in the contact lens maintenance solution of the present invention is selected from the group consisting of ethylenediaminetetraacetic acid (EDTA) and salts thereof, polyphosphates and salts thereof, and succinic acid. And a group consisting of salts, tartaric acid and salts thereof, tetraacetic acid and salts thereof. The aforementioned salts may be, for example, an alkali metal salt such as a sodium salt or a potassium salt, but are not limited thereto.
於本發明之一實施例,本發明之隱形眼鏡保養液中的界面活性劑係選自由泊洛沙姆(poloxamer)、泊洛沙姆之衍生物、泊洛沙明(poloxamine)、泊洛沙明之衍生物、檸檬酸鈉及陽離子表面活性劑所組成之群組。 In one embodiment of the present invention, the surfactant in the contact lens maintenance solution of the present invention is selected from the group consisting of poloxamer, poloxamer derivatives, poloxamine, and poloxa A group consisting of a derivative of the formula, sodium citrate, and a cationic surfactant.
於本發明之一實施例,本發明之隱形眼鏡保養液中的螯合劑添加量相對於100重量份的緩衝液,約為0.01重量份至1.0重量份,較佳為0.02重量份至0.05重量份。 In one embodiment of the present invention, the amount of the chelating agent added to the contact lens maintenance solution of the present invention is from about 0.01 part by weight to 1.0 part by weight, preferably from 0.02 part by weight to 0.05 part by weight, per 100 parts by weight of the buffer solution. .
於本發明之一實施例,本發明之隱形眼鏡保養液中的界面活性劑添加量相對於100重量份的緩衝液,約為0.1重量份至1.0重量份,較佳為0.6重量份至0.7重量份。 In one embodiment of the present invention, the amount of the surfactant added in the contact lens maintenance solution of the present invention is from about 0.1 part by weight to 1.0 part by weight, preferably from 0.6 part by weight to 0.7% by weight based on 100 parts by weight of the buffer solution. Share.
於本發明之一實施例,本發明之隱形眼鏡保養液進一步包括抗菌劑、抗氧化劑、增稠劑、張力調節劑、潤滑劑或其組合。 In an embodiment of the present invention, the contact lens maintenance solution of the present invention further comprises an antibacterial agent, an antioxidant, a thickener, a tonicity adjuster, a lubricant or a combination thereof.
於本發明之一實施例,本發明之隱形眼鏡保養液中的抗菌劑係選自由聚六亞甲基雙胍(PHMB)、聚六亞甲基雙胍之水溶性鹽、聚胺丙基雙胍(PAPB)、聚胺丙基雙胍之水溶性鹽、魚精蛋白(Protamine sulfate)或蜂毒素(Melittin)。 In an embodiment of the present invention, the antibacterial agent in the contact lens maintenance solution of the present invention is selected from the group consisting of polyhexamethylene biguanide (PHMB), water-soluble salt of polyhexamethylene biguanide, and polyaminopropyl biguanide (PAPB). ), a water-soluble salt of polyaminopropyl biguanide, Protamine sulfate or Melitin.
於本發明之一實施例,本發明之隱形眼鏡保養液中的抗菌劑添加量相對於100重量份的緩衝液,約為0.0001重量份至0.1重量份,較佳為0.0001重量份至0.03重量份。 In one embodiment of the present invention, the antibacterial agent is added in the contact lens maintenance solution of the present invention in an amount of about 0.0001 part by weight to 0.1 part by weight, preferably 0.0001 part by weight to 0.03 part by weight, per 100 parts by weight of the buffer solution. .
於本發明之一實施例,本發明之隱形眼鏡保養液中的抗氧化劑係選自亞硫酸鹽、抗壞血酸鹽、丁基化羥基苯甲醚(BHA)、丁基化羥基甲苯(BHT)、蝦紅素及維他命C所組成之群組。 In an embodiment of the present invention, the antioxidant in the contact lens maintenance solution of the present invention is selected from the group consisting of sulfite, ascorbate, butylated hydroxyanisole (BHA), butylated hydroxytoluene (BHT), and shrimp. A group of erythropoietin and vitamin C.
於本發明之一實施例,本發明之隱形眼鏡保養液中的抗氧化劑添加量相對於100重量份的緩衝液,約為0.001重量份至0.1重量份 In one embodiment of the present invention, the antioxidant is added in the contact lens maintenance solution of the present invention in an amount of about 0.001 part by weight to 0.1 part by weight based on 100 parts by weight of the buffer solution.
為了讓本發明之上述和其他目的、特徵、和優點能更明顯易懂,下文特舉較佳實施例,並配合所附化學式,作詳細說明如下。 The above and other objects, features, and advantages of the present invention will become more apparent and understood.
在本發明之一態樣中,本發明提供一種用於隱形眼鏡的保養液,包括一緩衝液、一螯合劑、一界面活性劑以及一保濕劑,該保濕劑包含具乙烯乙醯胺之聚合物、海藻酸及甘油,其中該保濕劑包含100重量份甘油、0.5至40重量份的含乙烯乙醯胺之聚合物及5至40重量份之海藻酸。 In one aspect of the invention, the invention provides a maintenance fluid for a contact lens comprising a buffer, a chelating agent, a surfactant, and a humectant, the humectant comprising a polymerization with ethylene acetamide And alginic acid and glycerin, wherein the humectant comprises 100 parts by weight of glycerin, 0.5 to 40 parts by weight of a polymer containing ethylene acetamide, and 5 to 40 parts by weight of alginic acid.
本發明所提出具清潔功能的隱形眼鏡保養液,因添加了具乙烯乙醯胺之聚合物、海藻酸以及甘油的保濕劑,故可提供生物相容性及低細胞毒性,降低眼睛過敏或紅腫現象,並於隱形眼鏡清潔後具良好潤濕性,以改善長期配戴所造成眼睛乾澀及痠脹。 The contact lens maintenance liquid with cleaning function provided by the invention can provide biocompatibility and low cytotoxicity, and reduce eye allergy or redness due to the addition of a humectant of ethylene glycol amine polymer, alginic acid and glycerin. Phenomenon, and good wettability after contact lens cleaning to improve dry eyes and soreness caused by long-term wear.
本發明之用於隱形眼鏡保養液的保濕劑需包含特定添加量的具乙烯乙醯胺之聚合物、海藻酸及甘油,一方面為具良好生物相容性及低細胞毒性及促使保濕劑易吸附於隱形眼鏡上,另一方面因甘油添加量低,故可避免保濕劑於眼球及鏡片中所形成的保濕層過度吸附眼球表面的水分子,而影響淚腺分泌。 The humectant for the contact lens maintenance liquid of the present invention needs to contain a specific amount of a polymer having ethylene acetamide, alginic acid and glycerin, on the one hand, having good biocompatibility and low cytotoxicity and promoting humectant Adsorption on contact lenses, on the other hand, due to the low amount of glycerin added, it can prevent the moisturizing layer formed by the moisturizer in the eyeball and the lens from excessively adsorbing water molecules on the surface of the eyeball, thereby affecting the secretion of lacrimal gland.
本發明之用於隱形眼鏡保養液的保濕劑之添加量相對於100重量份的緩衝液,約為0.01重量份至0.20重量份。較佳為約為0.04重量份至0.14重量份。 The amount of the humectant for the contact lens maintenance liquid of the present invention is from about 0.01 part by weight to 0.20 part by weight based on 100 parts by weight of the buffer. It is preferably from about 0.04 parts by weight to 0.14 parts by weight.
本發明之隱形眼鏡保養液之保濕劑中所使用的具乙烯乙醯胺之聚合物係可為乙烯乙醯胺均聚物或乙烯乙醯胺共聚物。前述乙烯乙醯胺均聚物係由乙烯乙醯胺單體聚合而成,例如可為日本SHOWA DENKO的GE-191系列之商品,其商品型號如下:GE-191-053、GE-191-103、GE-191-104GE-191-107或GE-191-108,但並不限於此。前述乙烯乙醯胺共聚物係由乙烯乙醯胺單體及其他具可交聯官能基之單體聚合而成,前述其他具可交聯官能基之單體例如可為丙烯酸鈉。此乙烯乙醯胺共聚物例如為日本SHOWA DENKO的GE-167之商品。為了使保濕劑能均勻吸附於隱形眼鏡上,故此含乙烯乙醯胺之聚合物的黏度係介於100mPa.s至20,000mPa.s之間,較佳係介於100mPa.s至3,000mPa.s之間。本發明之隱形眼鏡保養液的保濕劑中在100重量份甘油較佳含有1至35重量份的含 乙烯乙醯胺之聚合物。 The ethylene acetamide polymer used in the humectant for the contact lens maintenance liquid of the present invention may be a vinyl acetamide homopolymer or a vinyl acetamide copolymer. The ethylene acetamide homopolymer is polymerized from a vinyl acetamide monomer, and may be, for example, a product of the GE-191 series of SHOWA DENKO of Japan, and its product model is as follows: GE-191-053, GE-191-103 , GE-191-104GE-191-107 or GE-191-108, but not limited to this. The ethylene acetamide copolymer is obtained by polymerizing a vinyl acetamide monomer and another monomer having a crosslinkable functional group, and the other monomer having a crosslinkable functional group may be, for example, sodium acrylate. This ethylene acetamide copolymer is, for example, a product of GE-167 of Japan SHOWA DENKO. In order to make the humectant evenly adsorbed on the contact lens, the viscosity of the polymer containing ethylene acetamide is between 100 mPa. s to 20,000mPa. Between s, preferably between 100mPa. s to 3,000mPa. Between s. The humectant of the contact lens maintenance liquid of the present invention preferably contains 1 to 35 parts by weight of 100 parts by weight of glycerin. A polymer of ethylene acetamide.
本發明之隱形眼鏡保養液之保濕劑中適合使用的海藻酸之重量平均分子量範圍介於1,000至30,000之間,較佳介於5,000至20,000之間。當海藻酸的平均分子量大於或小於前述範圍,則會導致隱形眼鏡保養液對於蛋白質或脂質的清潔能力下降。本發明之隱形眼鏡保養液的保濕劑在100重量份甘油較佳含有10至35重量份之海藻酸。 The algal acid suitable for use in the humectant of the contact lens maintenance liquid of the present invention has a weight average molecular weight ranging from 1,000 to 30,000, preferably from 5,000 to 20,000. When the average molecular weight of alginic acid is greater than or less than the foregoing range, the cleaning ability of the contact lens maintenance solution for proteins or lipids is lowered. The humectant of the contact lens maintenance liquid of the present invention preferably contains 10 to 35 parts by weight of alginic acid in 100 parts by weight of glycerin.
再者,於本發明所提出隱形眼鏡保養液中,保濕劑進一步可包含玻尿酸。 Furthermore, in the contact lens maintenance solution of the present invention, the humectant may further comprise hyaluronic acid.
本發明之隱形眼鏡保養液之保濕劑中適合使用的玻尿酸之重量平均分子量範圍介於100,000至8,000,000之間,較佳介於100,000至1,300,000之間。當玻尿酸的平均分子量大於或小於前述範圍,亦導致隱形眼鏡保養液的清潔能力下降。且於保濕劑中可進一步加入20至70重量份之玻尿酸,較佳為加入20至67重量份之玻尿酸。 The hyaluronic acid suitable for use in the humectant of the contact lens maintenance liquid of the present invention has a weight average molecular weight ranging from 100,000 to 8,000,000, preferably from 100,000 to 1,300,000. When the average molecular weight of hyaluronic acid is greater than or less than the foregoing range, the cleaning ability of the contact lens maintenance solution is also lowered. Further, 20 to 70 parts by weight of hyaluronic acid may be further added to the humectant, preferably 20 to 67 parts by weight of hyaluronic acid.
於本發明所提出的隱形眼保養液之保濕劑,其中形成該保濕劑之各組分可經混合後添加於緩衝液或可個別添加至緩衝液。 In the moisturizing agent for the invisible eye care solution proposed by the present invention, the components forming the moisturizing agent may be added to the buffer after mixing or may be separately added to the buffer.
本發明之隱形眼鏡保養液的緩衝液是用以將隱形眼鏡保養液的pH值控制在一較佳的範圍內,例如在6至8之可接受之範圍內。由於隱形眼鏡保養液會吸附在隱形眼鏡上,因此隱形眼鏡保養液的pH值越接近人體組織液的pH值7.4,則會提高眼睛的舒適度。於本發明之一實施例,隱形眼鏡保養液中的緩衝液係由水、氯化鈉、硼酸及硼酸鹽所組成。 The buffer of the contact lens maintenance solution of the present invention is used to control the pH of the contact lens maintenance solution within a preferred range, for example, within an acceptable range of 6 to 8. Since the contact lens maintenance solution is adsorbed on the contact lens, the closer the pH value of the contact lens maintenance solution is to the pH value of the body tissue fluid 7.4, the eye comfort is improved. In one embodiment of the invention, the buffer in the contact lens maintenance fluid consists of water, sodium chloride, boric acid, and borate.
隱形眼鏡保養液中所使用的緩衝液只要與生理學相容之緩衝液均可使用,例如可由硼酸鹽、磷酸鹽、檸檬酸鹽、硼酸、碳酸鹽及乙酸鹽所組成之群組所組成。前述鹽類例如可為鹼金屬鹽,如鈉 鹽或鉀鹽。而緩衝液中的鹽類重量百分濃度一般係介於0.001wt%至5wt%之間。 The buffer used in the contact lens maintenance solution can be used as long as it is compatible with a physiologically compatible buffer, for example, a group consisting of borate, phosphate, citrate, boric acid, carbonate, and acetate. The aforementioned salts may be, for example, an alkali metal salt such as sodium. Salt or potassium salt. The concentration of the salt in the buffer is generally between 0.001% and 5% by weight.
本發明之隱形眼鏡保養液的螯合劑係選自由乙二胺四乙酸(EDTA)及其鹽、聚磷酸鹽(polyphosphates)及其鹽、琥珀酸(succinic acid)及其鹽、酒石酸(tartaric acid)及其鹽、四醋酸(tetraacetic acid)及其鹽所組成之群組。前述鹽類例如可為鹼金屬鹽,如鈉鹽或鉀鹽。前述螯合劑之添加量相對於100重量份的緩衝液,約為0.01重量份至1.0重量份,較佳為約為0.02重量份至0.05重量份。 The chelating agent for the contact lens maintenance solution of the present invention is selected from the group consisting of ethylenediaminetetraacetic acid (EDTA) and salts thereof, polyphosphates and salts thereof, succinic acid and salts thereof, and tartaric acid. And a group of its salts, tetraacetic acid and its salts. The aforementioned salts may be, for example, an alkali metal salt such as a sodium salt or a potassium salt. The amount of the chelating agent added is from about 0.01 part by weight to 1.0 part by weight, preferably from about 0.02 part by weight to 0.05 part by weight, per 100 parts by weight of the buffer.
於本發明之一實施例中,隱形眼鏡保養液中的螯合劑係使用乙二胺四乙酸二鈉。 In one embodiment of the invention, the chelating agent in the contact lens maintenance solution uses disodium edetate.
本發明之隱形眼鏡保養液的界面活性劑可選自由由泊洛沙姆(poloxamer)、泊洛沙姆之衍生物、泊洛沙明(poloxamine)、泊洛沙明之衍生物、檸檬酸鈉及陽離子表面活性劑所組成之群組。泊洛沙姆(poloxamer)例如可為但不限於Poloxamer 407、Pluronic® L35、L43、L44、L62、L62D、L62LF、L64、L92、F108、F123、F88、F98、F68、F68LF、F127、F87、F77、P84、P85、P75、P103、P104或P105。而泊洛沙姆(poloxamer)之衍生物意謂具官能基修飾之泊洛沙姆。泊洛沙明(poloxamine)例如可為但不限於Tetronic® 707、1107、1307、908或1304,而泊洛沙明(poloxamine)之衍生物意謂具官能基修飾之泊洛沙明。前述界面活性劑之添加量相對於100重量份的緩衝液,約為0.1重量份至1.0重量份,較佳為0.6重量份至0.7重量份。 The surfactant of the contact lens maintenance solution of the present invention may be selected from poloxamer, poloxamer derivatives, poloxamine, poloxamer derivatives, sodium citrate and A group consisting of cationic surfactants. The poloxamer may be, for example but not limited to, Poloxamer 407, Pluronic® L35, L43, L44, L62, L62D, L62LF, L64, L92, F108, F123, F88, F98, F68, F68LF, F127, F87, F77, P84, P85, P75, P103, P104 or P105. A derivative of poloxamer means a poloxamer having a functional group modification. The poloxamine can be, for example but not limited to, Tetronic® 707, 1107, 1307, 908 or 1304, and the poloxamine derivative means a poloxaamine having a functional group modification. The amount of the surfactant added is from about 0.1 part by weight to 1.0 part by weight, preferably from 0.6 part by weight to 0.7 part by weight, per 100 parts by weight of the buffer.
於本發明之一實施例中,隱形眼鏡保養液中的界面活性劑係使用泊洛沙姆及檸檬酸鈉。 In one embodiment of the invention, the surfactant in the contact lens maintenance fluid uses poloxamer and sodium citrate.
又,本發明之隱形眼鏡保養液進一步包括抗菌劑、抗氧 化劑、增稠劑、張力調節劑、潤滑劑或其組合。 Moreover, the contact lens maintenance solution of the present invention further comprises an antibacterial agent and an antioxidant. a chemical, a thickener, a tonicity modifier, a lubricant, or a combination thereof.
適合的抗菌劑例如可為聚六亞甲基雙胍(PHMB)、聚六亞甲基雙胍之水溶性鹽、聚胺丙基雙胍(PAPB)、聚胺丙基之水溶性鹽、硫酸魚精蛋白或蜂毒素。本發明所提出的抗菌劑,其添加量相對於100重量份的緩衝液,約為0.0001至0.1重量份,較佳約0.0001至0.03重量份。 Suitable antibacterial agents are, for example, polyhexamethylene biguanide (PHMB), water-soluble salts of polyhexamethylene biguanide, polyaminopropyl biguanide (PAPB), water-soluble salts of polyaminopropyl, protamine sulfate Or melittin. The antibacterial agent proposed by the present invention is added in an amount of about 0.0001 to 0.1 part by weight, preferably about 0.0001 to 0.03 part by weight, per 100 parts by weight of the buffer.
適合的抗氧化劑例如可為亞硫酸鹽、抗壞血酸鹽、丁基化羥基苯甲醚(BHA)、丁基化羥基甲苯(BHT)、蝦紅素及維他命C所組成之群組。本發明所提出的抗氧化劑,其添加量相對於100重量份的緩衝液,約為0.001重量份至0.1重量份。 Suitable antioxidants are, for example, the group consisting of sulfites, ascorbates, butylated hydroxyanisole (BHA), butylated hydroxytoluene (BHT), astaxanthin and vitamin C. The antioxidant proposed in the present invention is added in an amount of about 0.001 part by weight to 0.1 part by weight based on 100 parts by weight of the buffer.
適合的張力調節劑例如可為氯化鈉、氯化鉀或甘露醇。 Suitable tonicity adjusting agents can be, for example, sodium chloride, potassium chloride or mannitol.
下述實施例係用以進一步說明本發明,但本發明並不受其限制。 The following examples are intended to further illustrate the invention, but the invention is not limited thereto.
[隱形眼鏡保養液之製備方法] [Method for preparing contact lens maintenance solution]
關於製備實施例1-8之隱形眼鏡保養液的詳細組分請一併參考表1。 For detailed components of the contact lens maintenance liquids of Preparation Examples 1-8, please refer to Table 1.
實施例1 Example 1
將40重量份的水加熱至50℃,接著加入0.001重量份的乙烯乙醯胺與丙烯酸鈉所聚合之具乙烯乙醯胺之聚合物(商品名為adHERO GE167,購自SHOWA DENKO,日本)、0.1重量份的甘油、0.01重量份的海藻酸(CAS No 9005-38-3,平均分子量為222,購自Spectrum Chemical MFG CORP,US)以及0.02重量份的乙二胺四乙酸二鈉,經均勻攪拌直到完全溶解。 40 parts by weight of water was heated to 50 ° C, followed by the addition of 0.001 parts by weight of a vinyl acetamide polymer (trade name: adHERO GE167, available from SHOWA DENKO, Japan) polymerized with ethylene acetamide and sodium acrylate. 0.1 parts by weight of glycerin, 0.01 parts by weight of alginic acid (CAS No 9005-38-3, average molecular weight 222, available from Spectrum Chemical MFG CORP, US), and 0.02 parts by weight of disodium edetate, uniformly Stir until completely dissolved.
接著,將上述溶液冷卻至室溫後,接著加入0.6重量份的氯化鈉、0.05重量份的硼酸鈉、0.59重量份的硼酸、0.6重量份的檸檬 酸鈉、0.1重量份的泊洛沙姆(商品名poloxamer 407,CAS No.9003-11-6,購自Sigma Aldrich,美國),接著加入60重量份的水,經均勻攪拌直到完全溶解。 Next, after cooling the solution to room temperature, 0.6 parts by weight of sodium chloride, 0.05 parts by weight of sodium borate, 0.59 parts by weight of boric acid, and 0.6 parts by weight of lemon were added. Sodium, 0.1 parts by weight of poloxamer (trade name poloxamer 407, CAS No. 9003-11-6, available from Sigma Aldrich, USA), followed by the addition of 60 parts by weight of water, with uniform stirring until complete dissolution.
再將0.0001重量份的聚六亞甲基雙胍(PHMB,商品名為COSMOCIL CQ,CAS No.32289-58-0,購自瑞士的LONZA公司)添加至上述溶液中,經均勻攪拌直到完全溶解。 Further, 0.0001 part by weight of polyhexamethylene biguanide (PHMB, trade name COSMOCIL CQ, CAS No. 32289-58-0, available from LONZA, Switzerland) was added to the above solution, and uniformly stirred until completely dissolved.
最後將前述已加入抗菌劑之溶液經無菌過濾後封裝保存,即可完成隱形眼鏡保養液之製備。 Finally, the solution in which the antibacterial agent has been added is aseptically filtered and then stored in a package to complete the preparation of the contact lens maintenance solution.
實施例2 Example 2
實施例2的製備方法與實施例1相同,差異在於兩者的甘油添加量及泊洛沙姆添加量不同。 The preparation method of Example 2 was the same as that of Example 1, except that the amount of glycerin added and the amount of poloxamer added were different.
實施例3 Example 3
將40重量份的水加熱至50℃,接著加入0.001重量份的乙烯乙醯胺與丙烯酸鈉所聚合之乙烯乙醯胺共聚物(商品名為adHERO GE167,購自SHOWA DENKO,日本)、0.1重量份的甘油、0.01重量份的海藻酸(CAS No.9005-38-3,平均分子量為222,購自Spectrum Chemical MFG CORP,US)、0.02重量份的玻尿酸(CAS No.9067-32-7,平均分子量為325,000,購自Carbomer,Inc.,US)以及0.02重量份的乙二胺四乙酸二鈉,經均勻攪拌直到完全溶解。 40 parts by weight of water was heated to 50 ° C, followed by the addition of 0.001 parts by weight of ethylene acetamide copolymer (trade name: adHERO GE167, available from SHOWA DENKO, Japan) polymerized with ethylene acetamide and sodium acrylate, 0.1 weight Parts of glycerin, 0.01 parts by weight of alginic acid (CAS No. 9005-38-3, average molecular weight 222, available from Spectrum Chemical MFG CORP, US), 0.02 parts by weight of hyaluronic acid (CAS No. 9067-32-7, The average molecular weight was 325,000, available from Carbomer, Inc., US) and 0.02 parts by weight of disodium edetate, uniformly stirred until completely dissolved.
接著,將上述溶液冷卻至室溫後,接著加入0.6重量份的氯化鈉、0.05重量份的硼酸鈉、0.59重量份的硼酸、0.6重量份的檸檬酸鈉、0.1重量份的泊洛沙姆(商品名poloxamer 407,CAS No.9003-11-6,購自Sigma Aldrich,美國),最後加入60重量份的水,經均勻攪拌直到完全溶解。 Next, after cooling the solution to room temperature, 0.6 parts by weight of sodium chloride, 0.05 parts by weight of sodium borate, 0.59 parts by weight of boric acid, 0.6 parts by weight of sodium citrate, and 0.1 parts by weight of poloxamer were added. (trade name: poloxamer 407, CAS No. 9003-11-6, available from Sigma Aldrich, USA), and finally 60 parts by weight of water was added and uniformly stirred until completely dissolved.
再將0.0001重量份得聚六亞甲基雙胍(PHMB,商品名為COSMOCIL CQ,CAS No.32289-58-0,購自瑞士的LONZA公司)添加至上述溶液中,經均勻攪拌直到完全溶解。 Further, 0.0001 part by weight of polyhexamethylene biguanide (PHMB, trade name COSMOCIL CQ, CAS No. 32289-58-0, available from LONZA, Switzerland) was added to the above solution, and uniformly stirred until completely dissolved.
實施例4 Example 4
實施例4的製備方法與實施例3相同,差異在於兩者所添加的甘油、泊洛沙姆及含具乙烯乙醯胺之聚合物的添加量不同。 The preparation method of Example 4 was the same as that of Example 3, except that the amount of glycerin, poloxamer, and the polymer containing ethylene acetamide added was different.
實施例5 Example 5
實施例5的製備方法與實施例3相同,差異在於兩者所添加的甘油、泊洛沙姆及玻尿酸的添加量不同。 The preparation method of Example 5 was the same as that of Example 3, except that the amounts of glycerin, poloxamer, and hyaluronic acid added were different.
實施例6 Example 6
實施例6的製備方法與實施例5相同,差異在於實施例6的抗菌劑為魚精蛋白,其購自美國的Sigma Aldrich公司(CAS No.53594-25-4)以及所使用的乙二胺四乙酸二鈉的添加量不同。 The preparation method of Example 6 was the same as that of Example 5, except that the antibacterial agent of Example 6 was protamine, which was purchased from Sigma Aldrich Co., USA (CAS No. 53594-25-4) and ethylenediamine used. The amount of disodium tetraacetate added is different.
實施例7 Example 7
實施例7的製備方法與實施例5相同,差異在於實施例7所使用的抗菌劑為蜂毒素,其購自美國的Sigma Aldrich公司(CAS No.20449-79-0)以及所使用的乙二胺四乙酸二鈉的添加量不同。 The preparation method of Example 7 was the same as that of Example 5, except that the antibacterial agent used in Example 7 was a melittin which was purchased from Sigma Aldrich Co., Ltd. (CAS No. 20449-79-0) and the used E2. The amount of disodium edetate added is different.
實施例8 Example 8
將40重量份的水加熱至50℃,接著加入0.001重量份的乙烯乙醯胺與丙烯酸鈉所聚合之具乙烯乙醯胺之聚合物(商品名為adHERO GE167,購自SHOWA DENKO,日本)、0.03重量份的甘油、0.01重量份的海藻酸(CAS No.9005-38-3,平均分子量為222,購自Spectrum Chemical MFG CORP,US)、0.01重量份的玻尿酸(CAS No.9067-32-7,平均分子量為325,000,購自Carbomer,Inc.,US)以及0.05重量份的乙二胺四乙酸二鈉, 經均勻攪拌直到完全溶解。 40 parts by weight of water was heated to 50 ° C, followed by the addition of 0.001 parts by weight of a vinyl acetamide polymer (trade name: adHERO GE167, available from SHOWA DENKO, Japan) polymerized with ethylene acetamide and sodium acrylate. 0.03 parts by weight of glycerin, 0.01 parts by weight of alginic acid (CAS No. 9005-38-3, average molecular weight 222, available from Spectrum Chemical MFG CORP, US), 0.01 parts by weight of hyaluronic acid (CAS No. 9067-32- 7, an average molecular weight of 325,000, available from Carbomer, Inc., US) and 0.05 parts by weight of disodium edetate, Stir well until completely dissolved.
接著,將上述溶液冷卻至室溫後,接著加入0.6重量份的氯化鈉、0.05重量份的硼酸鈉、0.59重量份的硼酸、0.6重量份的檸檬酸鈉、0.01重量份的泊洛沙姆(商品名poloxamer 407,CAS No.9003-11-6,購自Sigma Aldrich,美國)以及0.001重量份的蝦紅素(購自茂世興業有限公司,台灣),最後加入60重量份的水,經均勻攪拌直到完全溶解。 Next, after cooling the solution to room temperature, 0.6 parts by weight of sodium chloride, 0.05 parts by weight of sodium borate, 0.59 parts by weight of boric acid, 0.6 parts by weight of sodium citrate, and 0.01 parts by weight of poloxamer are added. (trade name: poloxamer 407, CAS No. 9003-11-6, available from Sigma Aldrich, USA) and 0.001 parts by weight of astaxanthin (purchased from Mosch Industrial Co., Ltd., Taiwan), and finally added 60 parts by weight of water. Stir well until completely dissolved.
再將0.0001重量份得聚六亞甲基雙胍(PHMB,商品名為COSMOCIL CQ,CAS No.為32289-58-0,購自瑞士的LONZA公司)添加至上述溶液中,經均勻攪拌直到完全溶解。 Further, 0.0001 part by weight of polyhexamethylene biguanide (PHMB, trade name COSMOCIL CQ, CAS No. 32289-58-0, available from LONZA, Switzerland) was added to the above solution, and uniformly stirred until completely dissolved. .
接著將實施例1-8所配製的隱形眼鏡保養液依下列方法進行特性評估及殺菌功效測試,評估結果請參考表2及表3。 Next, the contact lens maintenance liquid prepared in Examples 1-8 was subjected to the characteristic evaluation and the bactericidal efficacy test according to the following methods. For the evaluation results, please refer to Table 2 and Table 3.
[接觸角測試] [contact angle test]
將市售矽水膠鏡片(商品名Oasys,購自台灣嬌生股份有限公司)及市售水膠鏡片(商品名TICON55,購自台灣精華光學股份有限公司)分別浸泡於實施例1至實施例8所配製的隱形眼鏡保養液中,浸泡時間為24小時,接著取出鏡片進行接觸角測試。 Commercially available hydrophobic plastic lenses (trade name Oasys, purchased from Taiwan Jiaosheng Co., Ltd.) and commercially available water gel lenses (trade name TICON55, purchased from Taiwan Essence Optical Co., Ltd.) were respectively immersed in Examples 1 to 1 In the prepared contact lens maintenance solution, the soaking time was 24 hours, and then the lens was taken out for the contact angle test.
[去蛋白質率的測試方法] [Test method for protein removal rate]
將市售矽水膠鏡片(商品名Oasys,購自台灣嬌生股份有限公司)及市售水膠鏡片(商品名TICON55,購自台灣精華光學股份有限公司)分別浸泡於具有3毫升的溶菌酶溶液的聚丙烯樣品管,並用聚丙烯保護蓋密封樣品管後,在37℃恒溫烘箱中培養12小時。接著將鏡片取出,利用紙巾吸附鏡片表面的溶菌酶溶液,而樣品管中的溶液則用來進行溶菌酶含量實驗,此時量測到的溶菌酶量測值為W1。而取出的鏡片則再浸泡在具有2毫升的鏡片萃取溶液(乙腈體積:三氟乙酸體積:水體積= 100:0.2:100)的聚丙烯製樣品管中,並在37℃下用旋轉震盪器(Red Rotor)搖晃樣品管24小時,最後將鏡片取出,並對萃取溶液進行溶菌酶含量測定實驗,此時量測到的溶菌酶量測值為W2。去蛋白質率的計算方式為[W1/(W1+W2)]*100%。 The commercially available hydrophobic plastic lens (trade name Oasys, purchased from Taiwan Jiaosheng Co., Ltd.) and the commercially available water plastic lens (trade name TICON55, purchased from Taiwan Essence Optical Co., Ltd.) were respectively immersed in 3 ml of lysozyme. The polypropylene sample tube of the solution was sealed with a polypropylene protective cap and incubated for 12 hours in a 37 ° C constant temperature oven. Then, the lens was taken out, and the lysozyme solution on the surface of the lens was adsorbed by a paper towel, and the solution in the sample tube was used for the lysozyme content experiment, and the measured lysozyme was measured as W1. The removed lens is then immersed in a lens extraction solution with 2 ml (acetonitrile volume: trifluoroacetic acid volume: water volume = 100:0.2:100) in a polypropylene sample tube, and shake the sample tube with a rotary shaker (Red Rotor) at 37 ° C for 24 hours, finally take out the lens, and perform a lysozyme content measurement experiment on the extraction solution. The measured lysozyme measurement was W2. The protein removal rate is calculated as [W1/(W1+W2)]*100%.
[去脂質率的測試方法] [Test method for delipidation rate]
將市售矽水膠鏡片(商品名Oasys,購自台灣嬌生股份有限公司)及市售水膠鏡片(商品名TICON55,購自台灣精華光學股份有限公司)分別浸泡於具有3毫升的膽固醇溶液的聚丙烯樣品管,並用聚丙烯保護蓋密封樣品管後,在37℃恒溫烘箱中培養12小時。接著將鏡片取出,利用紙巾吸附鏡片表面的膽固醇溶液,而樣品管中的溶液則用來進行膽固醇含量實驗,此時量測到的膽固醇量測值為P1。而取出的鏡片則再浸泡在具有2毫升的鏡片萃取溶液(氯仿體積:甲醇體積=2:1)的聚丙烯製樣品管中,並在37℃下用旋轉震盪器(Red Rotor)搖晃樣品管24小時,最後將鏡片取出,並對萃取溶液進行膽固醇含量測定實驗,此時量測到的膽固醇量測值為P2。去脂質率的計算方式為[P1/(P1+P2)]*100%。 The commercially available hydrophobic gel lens (trade name Oasys, purchased from Taiwan Jiaosheng Co., Ltd.) and commercially available water gel lens (trade name TICON55, purchased from Taiwan Essence Optics Co., Ltd.) were respectively immersed in a 3 ml cholesterol solution. The polypropylene sample tube was sealed with a polypropylene protective cap and incubated for 12 hours in a 37 ° C constant temperature oven. The lens is then removed, the cholesterol solution on the surface of the lens is adsorbed by a paper towel, and the solution in the sample tube is used for the cholesterol content test, and the measured cholesterol value is P1. The removed lens was then immersed in a polypropylene sample tube with 2 ml of lens extraction solution (chloroform volume: methanol volume = 2:1), and the sample tube was shaken at 37 ° C with a rotary shaker (Red Rotor). After 24 hours, the lens was finally taken out, and the extraction solution was subjected to a cholesterol content measurement experiment. At this time, the measured cholesterol value was P2. The lipid removal rate was calculated as [P1/(P1+P2)]*100%.
[殺菌功效測試] [Bactericidal efficacy test]
將市售矽水膠鏡片(商品名Oasys,購自台灣嬌生股份有限公司)及市售水膠鏡片(商品名TICON55,購自台灣精華光學股份有限公司)根據眼科光學國際標準ISO14729(International Standards for Ophthalmic Optics)進行殺菌功效測試,測試時間分為別6小時及24小時。「○」代表測試結果符合ISO標準,「×」代表測試結果未達ISO標準。 Commercially available hydrophobic plastic lenses (trade name Oasys, purchased from Taiwan Jiaosheng Co., Ltd.) and commercially available water plastic lenses (trade name TICON55, purchased from Taiwan Essence Optical Co., Ltd.) according to International Standards for Ophthalmic Optics ISO 14729 (International Standards) For Ophthalmic Optics) For bactericidal efficacy testing, the test time is divided into 6 hours and 24 hours. "○" means that the test results conform to the ISO standard, and "X" means that the test results are not up to the ISO standard.
由表2的特性數據結果可知,矽水膠鏡片經本發明之實施例1至實施例8的隱形眼鏡保養液浸泡後,接觸角為10.1°至15.1°,蛋白 質清洗率為55%至63.2%,脂質清洗率為45.9%至60.1%。 From the results of the characteristic data of Table 2, it is known that the hydrophobic gel lens is soaked by the contact lens maintenance solution of Examples 1 to 8 of the present invention, and the contact angle is 10.1 to 15.1 °, and the protein The cleaning rate was 55% to 63.2%, and the lipid cleaning rate was 45.9% to 60.1%.
而水膠鏡片經本發明之實施例1至實施例8的隱形眼鏡保養液浸泡後,接觸角為10.5°至11.8°,蛋白質清洗率為47.7%至56.0%,脂質清洗率為44.9%至58.5%。故本發明所提出的隱形眼鏡保養液,不論是用於矽水膠鏡片或水膠鏡片的清潔保養,其接觸角皆可維持於15.8°以下,因此,鏡片表面皆具有良好的保濕效果,再者,蛋白質清洗率及脂質清洗率皆約可達45%以上。 When the hydrocolloid lens is immersed in the contact lens maintenance liquid of Examples 1 to 8 of the present invention, the contact angle is 10.5° to 11.8°, the protein cleaning rate is 47.7% to 56.0%, and the lipid cleaning rate is 44.9% to 58.5%. . Therefore, the contact lens maintenance solution proposed by the present invention can maintain the contact angle of 15.8° or less regardless of the cleaning and maintenance of the water-repellent lens or the water-based lens. Therefore, the surface of the lens has a good moisturizing effect, and then The protein cleaning rate and lipid cleaning rate are all about 45%.
從表3的抗菌功效測試可知實施例1至實施例8的隱形眼鏡保養液對於大腸桿菌、金黃色葡萄球菌及綠膿桿菌皆可符合ISO的殺菌標準。 From the antibacterial efficacy test of Table 3, it is understood that the contact lens maintenance solutions of Examples 1 to 8 can comply with the ISO sterilization standard for Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa.
雖然本發明已以較佳實施例揭露如上,然其並非用以限定本發明,任何熟習此技藝者,在不脫離本發明之精神和範圍內,當可作些許之更動與潤飾,因此本發明之保護範圍當視後附之申請專利範圍所界定者為準。 While the present invention has been described in its preferred embodiments, the present invention is not intended to limit the invention, and the present invention may be modified and modified without departing from the spirit and scope of the invention. The scope of protection is subject to the definition of the scope of the patent application.
Claims (12)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610919508.0A CN106967515A (en) | 2016-04-19 | 2016-10-21 | Contact lens maintenance liquid |
US15/397,642 US9926515B2 (en) | 2016-04-19 | 2017-01-03 | Contact lens care solution |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW105112069 | 2016-04-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
TWI602912B true TWI602912B (en) | 2017-10-21 |
TW201738367A TW201738367A (en) | 2017-11-01 |
Family
ID=61011237
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW105128206A TWI602912B (en) | 2016-04-19 | 2016-09-01 | Contact lenses care solution |
Country Status (1)
Country | Link |
---|---|
TW (1) | TWI602912B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI798498B (en) * | 2019-10-23 | 2023-04-11 | 永勝光學股份有限公司 | Solution with high antimicrobial ability and lubricating effect |
-
2016
- 2016-09-01 TW TW105128206A patent/TWI602912B/en active
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI798498B (en) * | 2019-10-23 | 2023-04-11 | 永勝光學股份有限公司 | Solution with high antimicrobial ability and lubricating effect |
Also Published As
Publication number | Publication date |
---|---|
TW201738367A (en) | 2017-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI434926B (en) | Use of peo-pbo block copolymers in ophthalmic compositions | |
CN1942571A (en) | Cetylpyridinium chloride as an antimicrobial agent in ophthalmic compositions | |
JP6871334B2 (en) | Compositions for contact lenses and contact lens packages using them | |
EP0942065B1 (en) | Liquid for contact lensens | |
KR20050083693A (en) | Compositions with enhanced antimicrobial efficacy against acanthamoebae | |
EP2439579A1 (en) | Wettable hydrogel contact lens and method for producing same | |
TWI480039B (en) | Aqueous composition for contact lens | |
EP2365806A1 (en) | Ophthalmic solutions, including contact lens care solutions and eye drops comprising carnosine, preferably in combination with dexpanthenol and/or hyaluronic acid | |
TWI798452B (en) | Contact lens product | |
TWI602912B (en) | Contact lenses care solution | |
US9926515B2 (en) | Contact lens care solution | |
JPWO2005002595A1 (en) | Ophthalmic composition | |
JP2008209677A (en) | Germicide deactivating liquid agent | |
JP6066237B2 (en) | Antibacterial ophthalmic contact lenses | |
JPWO2004084877A1 (en) | Ophthalmic composition | |
WO2005123148A1 (en) | Composition for contact lens | |
CN108853556A (en) | A kind of contact lens,hard care composition and preparation method thereof containing sodium lactate | |
WO2007073480A1 (en) | A method for cleaning and maintaining contact lenses and related system and kit | |
WO2020140365A1 (en) | Moisturizing and lubricating composition containing xanthan gum and use thereof | |
JP2016133594A (en) | Preservative solution for contact lens, contact lens preservation method and contact lens manufacturing method | |
CN1302765C (en) | Ophthalmic solution containing borneol and usage thereof | |
JP5407688B2 (en) | Treatment solution for contact lenses | |
CN100337694C (en) | Compositions with enhanced antimicrobial efficacy against acanthamoebae | |
TWI652989B (en) | Composition and method for sterilizing and cleaning contact lenses | |
JP2015504181A (en) | Methods and kits for extending the use of contact lenses |